Bioengineering AG announces that Dr. Roland Durner has taken over the position of Chief Executive Officer (CEO) as of July 1, 2024. He succeeds Marc Bachmann, who has accepted a new professional challenge after 6 years.

During his tenure, Marc Bachmann has actively shaped Bioengineering and contributed to the positive development of the company and its corporate culture. The Board of Directors would like to thank him for his commitment and valuable contributions and wishes him all the best for his future endeavors.

The Chairman of the Board of Directors, Marcus Bernhardt, adds: "With Dr. Roland Durner, Bioengineering AG welcomes an experienced and visionary manager to the role of CEO. He has extensive experience and has demonstrated his outstanding skills in various management positions both nationally and internationally in recent years".

The Board of Directors of Bioengineering AG is confident that Dr. Roland Durner, with his experience and strategic vision, is the right person to further develop the company and lead it into a promising future. We wish him a successful start and look forward to a substantive and productive collaboration.